These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38933264)

  • 1. Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.
    Kang YH; Varghese PM; Aiyan AA; Pondman K; Kishore U; Sim RB
    Front Immunol; 2024; 15():1368852. PubMed ID: 38933264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
    Tan LA; Yang AC; Kishore U; Sim RB
    Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor H as a regulator of the classical pathway activation.
    Kishore U; Sim RB
    Immunobiology; 2012 Feb; 217(2):162-8. PubMed ID: 21852018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by phospholipids: the interplay of factor H and C1q.
    Tan LA; Yu B; Sim FC; Kishore U; Sim RB
    Protein Cell; 2010 Nov; 1(11):1033-49. PubMed ID: 21153520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR; Hwang HY; Boackle RJ
    Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands.
    Hester CG; Frank MM
    Mol Immunol; 2019 Dec; 116():117-130. PubMed ID: 31634815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of chondroitin sulfate A to the binding of complement proteins to activated platelets.
    Hamad OA; Nilsson PH; Lasaosa M; Ricklin D; Lambris JD; Nilsson B; Ekdahl KN
    PLoS One; 2010 Sep; 5(9):e12889. PubMed ID: 20886107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood platelets activate the classical pathway of human complement.
    Peerschke EI; Yin W; Grigg SE; Ghebrehiwet B
    J Thromb Haemost; 2006 Sep; 4(9):2035-42. PubMed ID: 16961611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.
    Hwang HY; Duvall MR; Tomlinson S; Boackle RJ
    Mol Immunol; 2008 May; 45(9):2570-80. PubMed ID: 18313756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.
    Gershov D; Kim S; Brot N; Elkon KB
    J Exp Med; 2000 Nov; 192(9):1353-64. PubMed ID: 11067883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
    Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
    J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.
    Kang M; Ko YP; Liang X; Ross CL; Liu Q; Murray BE; Höök M
    J Biol Chem; 2013 Jul; 288(28):20520-31. PubMed ID: 23720782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
    Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.
    Pondman KM; Pednekar L; Paudyal B; Tsolaki AG; Kouser L; Khan HA; Shamji MH; Ten Haken B; Stenbeck G; Sim RB; Kishore U
    Nanomedicine; 2015 Nov; 11(8):2109-18. PubMed ID: 26169151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.